Geode Capital Management
SYRE icon

Geode Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.4M Buy
1,227,232
+167,669
+16% +$2.51M ﹤0.01% 2000
2025
Q1
$17.1M Buy
1,059,563
+93,434
+10% +$1.51M ﹤0.01% 1976
2024
Q4
$22.5M Buy
966,129
+75,081
+8% +$1.75M ﹤0.01% 1905
2024
Q3
$26.2M Buy
891,048
+125,214
+16% +$3.68M ﹤0.01% 1833
2024
Q2
$18M Buy
765,834
+435,609
+132% +$10.2M ﹤0.01% 1987
2024
Q1
$12.5M Buy
330,225
+299,899
+989% +$11.4M ﹤0.01% 2191
2023
Q4
$653K Buy
30,326
+3,526
+13% +$75.9K ﹤0.01% 3516
2023
Q3
$328K Sell
26,800
-573,655
-96% -$7.03M ﹤0.01% 3777
2023
Q2
$271K Hold
600,455
﹤0.01% 3907
2023
Q1
$174K Hold
600,455
﹤0.01% 4119
2022
Q4
$270K Buy
600,455
+206,435
+52% +$92.8K ﹤0.01% 3938
2022
Q3
$207K Hold
394,020
﹤0.01% 4190
2022
Q2
$199K Sell
394,020
-298,201
-43% -$151K ﹤0.01% 4271
2022
Q1
$1.59M Buy
692,221
+6,476
+0.9% +$14.9K ﹤0.01% 3373
2021
Q4
$3.26M Sell
685,745
-4,252
-0.6% -$20.2K ﹤0.01% 3129
2021
Q3
$5.49M Buy
689,997
+12,271
+2% +$97.5K ﹤0.01% 2854
2021
Q2
$4.72M Buy
677,726
+19,856
+3% +$138K ﹤0.01% 2950
2021
Q1
$5.21M Buy
657,870
+90,857
+16% +$720K ﹤0.01% 2771
2020
Q4
$4.46M Sell
567,013
-1,445
-0.3% -$11.4K ﹤0.01% 2662
2020
Q3
$4.03M Sell
568,458
-14,186
-2% -$101K ﹤0.01% 2528
2020
Q2
$5.39M Buy
582,644
+263,564
+83% +$2.44M ﹤0.01% 2302
2020
Q1
$1.49M Buy
319,080
+5,909
+2% +$27.5K ﹤0.01% 2828
2019
Q4
$2.39M Buy
313,171
+684
+0.2% +$5.22K ﹤0.01% 2902
2019
Q3
$2.4M Buy
312,487
+13,406
+4% +$103K ﹤0.01% 2829
2019
Q2
$2.05M Buy
299,081
+58,345
+24% +$400K ﹤0.01% 2937
2019
Q1
$1.94M Buy
240,736
+78,139
+48% +$629K ﹤0.01% 2875
2018
Q4
$1.22M Buy
162,597
+8,310
+5% +$62.2K ﹤0.01% 3023
2018
Q3
$1.48M Buy
154,287
+6,883
+5% +$65.8K ﹤0.01% 3047
2018
Q2
$1.56M Buy
147,404
+116,755
+381% +$1.23M ﹤0.01% 2992
2018
Q1
$304K Hold
30,649
﹤0.01% 3563
2017
Q4
$165K Hold
30,649
﹤0.01% 3719
2017
Q3
$145K Hold
30,649
﹤0.01% 3738
2017
Q2
$117K Sell
30,649
-2,493
-8% -$9.52K ﹤0.01% 3810
2017
Q1
$246K Buy
33,142
+9,831
+42% +$73K ﹤0.01% 3584
2016
Q4
$101K Buy
23,311
+4,092
+21% +$17.7K ﹤0.01% 3793
2016
Q3
$123K Buy
+19,219
New +$123K ﹤0.01% 3755